Table. 2. Immune Parameters at last follow up.
| Pt | Age at HSCT |
Age at F/U |
ANC | CD13 | CD4 (abs#) |
CD19 (abs#) |
PHA + 10ug/ml |
ConA + 10ug/ml |
Candida (SI) |
Tetanus (SI) |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 30 mo | 5 yrs | 2262 | 1.647 (1.4–3.7) |
709 (0.7–2.2) |
538 (0.4–1.4) |
297328 | 267247 | 4516 | 30944 |
| 2 | 45 mo | 8 yrs | 1367 | 1.789 (1.2–2.6) |
810 (0.65–1.5) |
0.635 (0.2–.86) |
304466 | 313285 | 2586 | 43710 |
| 3 | 41 mo | 6 yrs | 2690 | 1.874 (1.4–3.7) |
1.192 (0.7–2.2) |
2.121 (0.4–1.4) |
426433 | 324072 | N/A | 763 |
| 4 | 8.3 yrs | 10 yrs | 2650 | 1.034 (1.2–2.6) |
0.423 (0.65–1.5) |
0.103 (0.4–1.4) |
152145 | N/A | N/A | N/A |
| 5 | 11 mo | 3 yrs | 4080 | 2.531 (1.4–3.7) |
1.554 (0.7–2.2) |
0.446 (0.4–1.4) |
309721 | 113562 | 5931 | 749 |
| 6 | 6.4 yrs | 9 yrs | 10301 | 1.801 (1.4–3.7) |
0.959 (0.65–1.5) |
0.773 (0.4–1.4) |
166508 | 141519 | 11093 | 61579 |
| 7 | 5.9 yrs | 6 yrs | 1820 | 0.367** (1.4–3.7) |
0.222** (0.7–2.2) |
0.403** (0.4–1.4) |
306364 | 242380 | 770 | 118 |
| 8 | 18 mo | 5 yrs | 2690 | 2.336 (1.4–3.7) |
1.164 (0.7–2.2) |
1.267 (0.4–1.4) |
74320 | 80528 | 281 | 304 |
| 9 | 7.4 yrs | 10 yrs | 3040 | 0.507 (1.2–2.6) |
0.288 (0.65–1.5) |
0.879 (0.4–1.4) |
118145 | 50525 | 247 | 14350 |
| 10 | 50 mo | 9 yrs | 2770 | 1.326 (1.2–2.6) |
0.916 (0.65–1.5) |
0.781 (0.4–1.4) |
253455 | 83238 | 2342 | 24138 |
| 11 | 13 yrs | 15 yrs | 2429 | 1054 (1–2.2) |
0.645 (0.5–1.3) |
0.679 (0.1–.6) |
277627 | 178714 | N/A | N/A |
( ) Normal values are presented as 10th and 90th percentiles. Subset counts (number of cell per micro liter x 10–3). 19
studies performed while on steroids for AIHA (Autoimmune hemolytic anemia).
Proliferation responses expressed as log of counts per minute (cpm)